BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

GEHC

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

  • GE HealthCare agrees to acquire Sofie Biosciences for $945 million to expand its radiopharmaceutical business in PET imagingOct 11, 2026
  • GE HealthCare received FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0Jun 4, 2026
  • GE HealthCare announced the first patient was dosed in the Phase 2/3 LUMINA trial for its manganese-based MRI contrast agentApr 23, 2026
  • GE HealthCare received FDA 510(k) clearance for View, a next-generation diagnostic viewer enabling radiologists to access images from anywhereMar 9, 2026
  • GE HealthCare reached an MRI milestone after receiving FDA clearances for next-generation SIGNA MRI technology aimed at improving imaging precision and clinical efficiencyFeb 20, 2026

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy